Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$751M |
| 2 |
Home Depot
HD
|
+$408M |
| 3 |
Altria Group
MO
|
+$378M |
| 4 |
SMBS
Schwab Mortgage-Backed Securities ETF
SMBS
|
+$298M |
| 5 |
Texas Instruments
TXN
|
+$260M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$868M |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$819M |
| 3 |
Amgen
AMGN
|
+$552M |
| 4 |
Merck
MRK
|
+$482M |
| 5 |
Cisco
CSCO
|
+$433M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.87% |
| 2 | Financials | 11.48% |
| 3 | Healthcare | 9.94% |
| 4 | Consumer Discretionary | 9.29% |
| 5 | Industrials | 8.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PVLA
2726
Palvella Therapeutics
PVLA
$2.26B
| $2.26M | ﹤0.01% |
21,633
+620
| +3% | +$52.9K |
|
|
NVMI
2727
Nova
NVMI
$13.1B
| $2.25M | ﹤0.01% |
6,844
+1,383
| +25% | +$445K |
|
2728
Telos
TLS
$344M
| $2.24M | ﹤0.01% |
439,401
-893
| -0.2% | -$5.57K |
|
2729
Citizens Financial Services
CZFS
$393M
| $2.22M | ﹤0.01% |
39,013
-19
| -0% | -$1.08K |
|
2730
Smith & Nephew
SNN
$12.6B
| $2.22M | ﹤0.01% |
67,772
+4,303
| +7% | +$147K |
|
2731
Design Therapeutics
DSGN
$901M
| $2.22M | ﹤0.01% |
236,863
-11,071
| -4% | -$86.7K |
|
2732
Ribbon Communications
RBBN
$377M
| $2.21M | ﹤0.01% |
769,074
-413
| -0.1% | -$1.33K |
|
2733
Arm
ARM
$298B
| $2.21M | ﹤0.01% |
20,228
-6,230
| -24% | -$906K |
|
2734
Compass Therapeutics
CMPX
$407M
| $2.2M | ﹤0.01% |
410,157
+74,907
| +22% | +$346K |
|
2735
Waterstone Financial
WSBF
$385M
| $2.19M | ﹤0.01% |
132,271
-113
| -0.1% | -$1.77K |
|
2736
Target Hospitality
TH
$1.62B
| $2.19M | ﹤0.01% |
273,163
+260
| +0.1% | +$1.97K |
|
|
BLLN
2737
BillionToOne Inc
BLLN
$4.44B
| $2.18M | ﹤0.01% |
+26,604
| New | +$2.7M |
|
2738
Atea Pharmaceuticals
AVIR
$406M
| $2.17M | ﹤0.01% |
607,792
-17,192
| -3% | -$54.6K |
|
2739
Holley
HLLY
$362M
| $2.16M | ﹤0.01% |
523,207
+39,792
| +8% | +$143K |
|
2740
Inhibrx
INBX
$1.42B
| $2.16M | ﹤0.01% |
27,341
-452
| -2% | -$30.8K |
|
2741
NRC Health Common Stock
NRC
$471M
| $2.16M | ﹤0.01% |
114,967
+18,067
| +19% | +$273K |
|
2742
Bumble
BMBL
$359M
| $2.16M | ﹤0.01% |
603,743
-24,441
| -4% | -$108K |
|
2743
Johnson Outdoors
JOUT
$512M
| $2.15M | ﹤0.01% |
50,669
+5,568
| +12% | +$230K |
|
2744
UroGen Pharma
URGN
$2.34B
| $2.13M | ﹤0.01% |
90,989
-70
| -0.1% | -$1.52K |
|
2745
Microvision
MVIS
$89.7M
| $2.12M | ﹤0.01% |
170,410
+7,980
| +5% | +$127K |
|
2746
ZipRecruiter
ZIP
$388M
| $2.1M | ﹤0.01% |
539,736
+23,572
| +5% | +$106K |
|
2747
Pulse Biosciences
PLSE
$3.2B
| $2.09M | ﹤0.01% |
152,420
-238
| -0.2% | -$3.71K |
|
2748
STMicroelectronics
STM
$48.1B
| $2.09M | ﹤0.01% |
80,667
-8,285
| -9% | -$213K |
|
2749
Mitek Systems
MITK
$853M
| $2.07M | ﹤0.01% |
196,588
-8,368
| -4% | -$79.1K |
|
2750
The RMR Group
RMR
$346M
| $2.05M | ﹤0.01% |
137,624
+12,083
| +10% | +$184K |
|
Similar funds
Charles Schwab's Q4 2025 Portfolio in Review
As of Q4 2025, Charles Schwab held 3,523 positions worth $644B, up 2.7% from $626B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Trading was light in Q4 2025: portfolio turnover was 3.8%. Charles Schwab opened 68 new positions and exited 67, leaving the 3,523-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 25% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q4 2025 buy was Qnity Electronics Inc: 1,489,517 shares worth $122M.
- Charles Schwab added most to Meta Platforms (Facebook) in Q4 2025, an estimated $751M increase.
- Charles Schwab's biggest Q4 2025 reduction was Broadcom, cutting an estimated $868M.
- Charles Schwab fully exited Vanguard S&P 500 ETF in Q4 2025, selling an estimated $819M.
- Charles Schwab's ten largest holdings make up 25% of its $644B portfolio in Q4 2025.
- Charles Schwab opened 68 new positions and closed 67 in Q4 2025.
- Charles Schwab's portfolio value rose 2.7% quarter-over-quarter to $644B.
Based on Charles Schwab's 13F filing for Q4 2025, filed 13 Feb 2026.